" class="no-js "lang="en-US"> Motoo Nishihara - Medtech Alert
Monday, June 17, 2024
Motoo Nishihara

Motoo Nishihara

About Motoo Nishihara

Related Story

NEC OncoImmunity Acquires VAXIMM's Neoantigen Vaccine Development Assets

March 9 2022

NEC OncoImmunity (NOI), a subsidiary of NEC Corporation (NEC), and VAXIMM AG, a Swiss/German biotech […]

Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine

November 23 2021

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment […]